Plasma Metabolite Signature Classifies Male LRRK2 Parkinson’s Disease Patients
Parkinson’s disease (PD) is a progressive neurodegenerative disease, causing loss of motor and nonmotor function. Diagnosis is based on clinical symptoms that do not develop until late in the disease progression, at which point the majority of the patients’ dopaminergic neurons are already destroyed. While many PD cases are idiopathic, hereditable genetic risks have been […]
Plasma Metabolite Signature Classifies Male LRRK2 Parkinson’s Disease Patients Read More »